News

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study

World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria…

1 year ago

Institute for Healthcare Advancement Announces PlainLanguage Pro: A Skill-Building Module That Equips Healthcare Writers, Designers, and Editors of Consumer-Facing Documents with Industry-Leading Health Literacy Best Practices and Principles

PlainLanguage Pro, a new course on how to create easier-to-understand-and-use health documents, helps healthcare professionals simplify complex information for all…

1 year ago

NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates

Target enrollment in the chronic cohort of our Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury…

1 year ago

Swell Launches Employee Experience Insights to Give Healthcare Organizations Real-Time Employee Feedback

HOLLADAY, UT / ACCESSWIRE / November 14, 2024 / Swell, a leader in feedback management solutions for the healthcare industry,…

1 year ago

MDaudit’s 2024 Benchmark Report Reveals a Fivefold Increase in Dollars At-Risk from Payer Audits while Coding-Related Denials Surged by Over 125%

Amid skyrocketing audit and denial rates, slower reimbursements, and lower dollars paid per claim, continuous risk monitoring will be crucial…

1 year ago

Zane Networks Awarded Blanket Purchase Agreement for Health and Human Services’ Health IT Alignment Initiative

WASHINGTON, DC / ACCESSWIRE / November 14, 2024 / Zane Networks, LLC, a leader in healthcare transformation services and solutions,…

1 year ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding…

1 year ago

Interactive Strength Inc. (Nasdaq:TRNR) Reports Third Quarter 2024 Results

Net Loss and Earnings per Diluted Share of $7.1 million and $1.53Adjusted EBITDA was a $2.3 million loss, a $1.0…

1 year ago

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform

Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI…

1 year ago

Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity

-- Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors -- -- Advancement of IkT-001Pro into a…

1 year ago